Home » Topics » BioWorld Science

BioWorld Science
RSS

Esteve patents voltage-dependent calcium channel subunit alpha2/delta-1 ligands

May 26, 2020

New SSAO inhibitors identified at Boehringer Ingelheim

May 26, 2020

AiCuris discovers HBV caspid assembly inhibitors

May 26, 2020

IRAK-2 is a therapeutic target in atopic dermatitis and psoriasis

May 26, 2020

First-in-human characterization of RPT-193

May 26, 2020

DNA-encoded immunotherapies show efficacy in models of N. gonorrhoeae infection

May 26, 2020

Clinical data for novel non-D2-receptor-binding compound in patients with schizophrenia

May 26, 2020

Enrollment open in phase II study of MSTT-1041A or UTTR-1147A in COVID-19 pneumonia

May 26, 2020

Karus Therapeutics initiates phase II study of KA-2507 in biliary tract cancer

May 26, 2020

p53 loss leads to immune evasion

May 26, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...